Ríos-Castillo JE, Velasco E, Arjona-Berral JE, Monserrat Jordán JA, Povedano-Cañizares B, Castelo-Branco C. Efficacy of Essure hysteroscopic sterilization--5 years follow up of 1200 women.
Gynecol Endocrinol 2013;
29:580-2. [PMID:
23557170 DOI:
10.3109/09513590.2013.777419]
[Citation(s) in RCA: 35] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE
To assess the efficacy of the Essure hysteroscopic birth control device after 5 years follow up.
STUDY DESIGN
Retrospective analysis of case series.
SETTING
Outpatient hysteroscopy facility in a large teaching hospital.
SUBJECTS
One-thousand three-hundred and twenty-one women who underwent hysteroscopic sterilization with Essure device (Conceptus, Inc., Mountain View, CA) between January 2003 and May 2005.
INTERVENTION(S)
Hysteroscopic tubal sterilization using Essure system.
MAIN OUTCOME MEASURE
Efficacy/effectiveness, failure rate.
RESULTS
Satisfactory insertion was accomplished in the first attempt in 1166 women (97.16%). After the second attempt, successful insertion rate rise to 98.6%. (n = 31, 2.6%). Three pregnancies had been reported after 5 years follow up, which implies an overall absolute rate of 0.25%. This represents a Pearl index of 0.05 after 72,000 months of surveillance. All of them occurred in the first year of use of the microinsert. There has been no unintended pregnancy in the next 4 years.
CONCLUSION(S)
Essure has the lowest Pearl index never published being the most effective permanent birth control system to date. Unintended pregnancies tend to occur in the first year after the insertion, and can be avoided encouraging women to accomplish the protocol.
Collapse